CareCloud, Inc. filings document operating results, Regulation FD presentation materials, governance actions, and capital-structure disclosures for a healthcare technology and revenue cycle management company. The records cover common stock, preferred-stock dividend and security matters, credit facility events, and formal updates tied to financial performance.
CareCloud’s proxy and current reports also disclose shareholder voting matters, bylaw amendments, board and audit committee composition, Nasdaq compliance items, and cybersecurity incident reporting. These filings frame the company’s Healthcare IT and Medical Practice Management activities alongside risk, governance, and public-company reporting obligations.
CareCloud, Inc. furnished materials related to its results of operations and financial condition. The company provided a press release and an accompanying slide presentation, delivered under Item 2.02 and Item 7.01, respectively. The materials are furnished and not deemed filed under the Exchange Act.
Exhibits include 99.1 (press release dated November 6, 2025), 99.2 (slide presentation dated November 6, 2025), and 104 (Cover Page Inline XBRL). CareCloud’s securities trade on the Nasdaq Global Market under CCLD (common stock) and CCLDO (8.75% Series B Preferred). The report was signed by Interim CFO and Corporate Controller Norman Roth.
CareCloud, Inc. (CCLD) filed an Amendment No. 1 to Form 8-K to complete its earlier acquisition disclosure for Medsphere Systems Corporation. The amendment adds the required financial statements of the acquired business and unaudited pro forma combined information under Item 9.01(a) and (b).
Exhibits include Medsphere’s audited financials as of December 31, 2024 and 2023, unaudited interim financials as of June 30, 2025, and unaudited pro forma condensed combined information covering the acquisitions of Medsphere, RevNu, and Mesa. Other disclosures from the original report remain unchanged.
CareCloud, Inc. filed a current report describing a new dividend announcement for its preferred shareholders. On October 7, 2025, the company issued a press release stating that its Board of Directors has declared monthly cash dividends for its Series A Cumulative Redeemable Perpetual Preferred Stock and its Series B Cumulative Redeemable Perpetual Preferred Stock covering October, November, and December 2025.
The details of the dividend payments, including specific amounts and payment dates, are provided in a press release that is furnished as Exhibit 99.1 under Regulation FD and incorporated by reference into this report.
Mahmud Ul Haq, identified as Executive Chairman, Director and a 10% owner of CareCloud, Inc. (CCLD), reported a sale of 11,960 shares of Series B Cumulative Redeemable Perpetual Preferred Stock (CCLDO) on 09/29/2025. The reported weighted-average sale price was $21.08, with transaction prices ranging from $20.91 to $21.23, and the filing states the sale reduced the reporting person’s beneficial ownership of this class to 0 shares. The Form 4 was executed by Norman Roth as attorney-in-fact and discloses the reporting person filed individually.
Form 144 notice for CCLD Preferred Series B: The filing reports a proposed sale of 11,960 shares of CCLDO Preferred Series B with an aggregate market value of $252,000 on an approximate sale date of 09/29/2025 on NASDAQ. The broker listed is Chapin Davis Investments (address provided). The securities were acquired from CareCloud, Inc. as compensation: 5,480 shares on 02/19/2022 and 6,480 shares on 12/16/2024, matching the total to be sold. The filer reports no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.